Revenue: As of FY2026 Q2, the actual value is USD 1.46 B, beating the estimate of USD 1.403 B.EPS: As of FY2026 Q2, the actual value is USD 4.46, beating the estimate of USD 4.065.<h4>Second Quarter Financial Highlights</h4>Net sales for The Scotts Miracle-Gro Company increased by 5% to $1.46 billion compared to the prior year. The GAAP gross margin rate improved by 280 basis points, and the non-GAAP adjusted gross margin rate improved by 240 basis points over the prior year, reaching 41.8%. Non-GAAP adjusted EBITDA improved by 9 percent over the prior year, reaching $437.4 million. Net leverage for the company improved to 3.71x, down from 4.41x in the prior year, representing a 0.70x improvement.<h4>Fiscal 2026 Outlook</h4>The Scotts Miracle-Gro Company reaffirmed its fiscal 2026 guidance, projecting low single-digit growth in U.S. Consumer net sales and mid single-digit growth in non-GAAP adjusted EBITDA. The company expects a non-GAAP adjusted gross margin rate of at least 32% and non-GAAP adjusted net income per share from continuing operations ranging from $4.15 to $4.35. Additionally, free cash flow is anticipated to be $275 million, which is expected to reduce the leverage ratio to the high 3s.

Scotts Miracle - Gro | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.46 B